Chester County News and Community Website
WILMINGTON, DE — A Wilmington man has been arrested for an alleged drug offense following an observation by law enforcement officers earlier this week.
Wilmington Man Arrested After Allegedly Caught with Over 173 Grams of Marijuana! Read More
WILMINGTON, DE — InterDigital, Inc. (Nasdaq: IDCC) announced that its Board of Directors has declared a quarterly cash dividend of $0.60 per share, payable on July 23, 2025, to shareholders …
InterDigital Announces $0.60 Quarterly Dividend for July 2025 Read More
WILMINGTON, DE — Onfolio Holdings Inc. (Nasdaq: ONFO, ONFOW; OTCQB: ONFOP) has announced the debut of its Referral Partner Program, designed to accelerate the growth of its Generative Engine Optimization …
Onfolio Launches Referral Partner Program to Expand Generative Engine Optimization Business Read More
WILMINGTON, DE — Global Indemnity Group, LLC (NYSE: GBLI) has announced the appointment of Jason C. Murgio, Principal and Chief Executive Officer of Merger & Acquisition Services, Inc., to its …
Global Indemnity Group Appoints Jason C. Murgio to Board of Directors Read More
WILMINGTON, DE — Incyte (Nasdaq: INCY) announced it recently granted restricted stock unit awards (RSUs) totaling 16,550 shares of common stock to 19 new employees. The awards were issued under …
Incyte Awards 16,550 RSUs to New Employees Under 2024 Inducement Plan Read More WILMINGTON, DE — Global Indemnity Group, LLC (NYSE: GBLI) has announced that its Board of Directors has approved a cash distribution of $0.35 per common share. The payment is scheduled …
Global Indemnity Group Declares $0.35 Dividend for Shareholders Read More
WILMINGTON, DE — Bin There Dump That has been named to Entrepreneur Magazine’s 2025 Franchise 500 list, achieving the #149 spot overall and ranking #1 in its category. The recognition …
Bin There Dump That Earns Top Industry Distinctions in 2025 Read More WILMINGTON, DE — Incyte (Nasdaq: INCY) is set to present pivotal data from its hematology/oncology portfolio at the 2025 European Hematology Association (EHA) Congress, scheduled for June 12–15 in Milan. …
Incyte to Showcase Groundbreaking Hematology/Oncology Data at EHA 2025 Read More
WILMINGTON, DE — The Phase III DESTINY-Breast09 clinical trial has delivered groundbreaking results, demonstrating that ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab significantly improves progression-free survival (PFS) for patients with HER2-positive metastatic …
ENHERTU plus Pertuzumab Shows Significant Progress in First-Line Treatment for HER2-Positive Breast Cancer Read More
WILMINGTON, DE — Enovis Corporation (NYSE: ENOV) announced its management team will participate in the following investor conferences:
Enovis to Present at Upcoming Investor Conferences in June Read More